HOME >> BIOLOGY >> NEWS
EMBO Installation Grants help scientists get set up in Europe

The European Molecular Biology Organization (EMBO) has singled out ten talented life scientists to receive EMBO Installation Grants, a new scheme that aims to strengthen science in selected member states of the EMBC, EMBOs intergovernmental funding body. The grants will help the scientists to relocate and set up their research groups in Croatia, the Czech Republic, Estonia, Poland, Portugal and Turkey.

EMBO Installation Grants are financed entirely by the EMBC Member States hosting the grantees. Each scientist will receive 50,000 euro annually for three to five years, giving them the extra resources they need to get their groups started and establish themselves in the European scientific community. Networking is a key part of this and grantees will be integrated into the prestigious EMBO Young Investigator network, putting them in touch with some of Europes best young group leaders and providing them with a range of career development and networking support.

This first application round for EMBO Installation Grants was highly competitive and the successful candidates were handpicked by a committee of EMBO Members for the high standard of their research. By bringing this level of scientific talent into the participating countries, EMBO hopes to help them become more competitive in European science. Three of the ten grantees will set up their groups in Poland, two in Portugal, two in Turkey and one in Croatia, the Czech Republic and Estonia respectively. Four scientists will move from positions in the USA and the rest will relocate from countries in and around Europe.

EMBO Executive Director, Frank Gannon said: "We congratulate this first group of scientists to receive EMBO Installation Grants and welcome them to the EMBO community. These talented researchers will benefit from a powerful support network in the coming years. Not only do they have the secure financial backing of their host countries but also the active interest and sup
'"/>

Contact: Lindsay Johnson
communications@embo.org
49-622-188-91108
European Molecular Biology Laboratory
8-Dec-2006


Page: 1 2

Related biology news :

1. Grants put ANU in bird flu fight frontline
2. Grants will give developing world access to scientific research
3. Grants to fund research on preparing for bioterrorist attack
4. Grants target better predictors for type 1 diabetes
5. UK scientists working to help cut ID theft
6. Smithsonian scientists show differing patterns of rainforest biodiversity
7. Weizmann Institute scientists discover a control mechanism for metastasis
8. Cornell scientists link E. coli bacteria to Crohns disease
9. UCLA scientists produce functioning neurons from human embryonic stem cells
10. ASBMB taps 8 scientists and 1 politician for top awards
11. UF, French scientists seek test to detect gene doping in athletes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EMBO Installation Grants help scientists get set Europe

(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... , 3.75% Convertible Senior Notes due May 1, ... per $1,000 principal amount or approximately $5.72 per share, effective ... note is adjusted in connection with the regular quarterly dividend ... stockholders who own shares of PDL on March 5, 2015, the ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
Cached News: